Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-08-28

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $135.42 per share (Direct)
  Date: 2026-08-28 | Code: M | equity_swap_involved: false | shares_owned_after: 333,943.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 480 shares of Common Stock at $514.257 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 333,463.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2
• Sold 1,630 shares of Common Stock at $515.4587 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 331,833.00 | transaction_form_type: 4 | Footnotes: F1, F4, F2
• Sold 2,386 shares of Common Stock at $516.1571 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 329,447.00 | transaction_form_type: 4 | Footnotes: F1, F5, F2
• Sold 1,486 shares of Common Stock at $517.1073 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 327,961.00 | transaction_form_type: 4 | Footnotes: F1, F6, F2
• Sold 1,346 shares of Common Stock at $518.1434 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 326,615.00 | transaction_form_type: 4 | Footnotes: F1, F7, F2
• Sold 412 shares of Common Stock at $519.1925 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 326,203.00 | transaction_form_type: 4 | Footnotes: F1, F8, F2
• Sold 751 shares of Common Stock at $520.2975 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 325,452.00 | transaction_form_type: 4 | Footnotes: F1, F9, F2
• Sold 286 shares of Common Stock at $521.5815 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 325,166.00 | transaction_form_type: 4 | Footnotes: F1, F10, F2
• Sold 517 shares of Common Stock at $522.4022 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 324,649.00 | transaction_form_type: 4 | Footnotes: F1, F11, F2
• Sold 6 shares of Common Stock at $523.425 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 324,643.00 | transaction_form_type: 4 | Footnotes: F1, F12, F2
• Sold 200 shares of Common Stock at $524.4175 per share (Direct)
  Date: 2026-08-28 | Code: S | equity_swap_involved: false | shares_owned_after: 324,443.00 | transaction_form_type: 4 | Footnotes: F1, F13, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | shares_owned_after: 40,513.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 249,108.00 | Footnotes: F14
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F15
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-28 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 8,902.00 | Footnotes: F16
• Sold 9,500 shares of Stock Option at $135.42 per share (Derivative)
  Date: 2026-08-28 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 37,410.00 | transaction_form_type: 4 | Footnotes: F1, F17

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
• F10: This transaction was executed in multiple trades at prices ranging from $520.92 to $521.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $522.00 to $522.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: This transaction was executed in multiple trades at prices ranging from $523.04 to $524.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F13: This transaction was executed in multiple trades at prices ranging from $524.04 to $524.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F14: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F15: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F16: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F17: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
• F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F3: This transaction was executed in multiple trades at prices ranging from $513.64 to $514.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $514.72 to $515.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $515.72 to $516.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $516.73 to $517.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $517.74 to $518.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $518.74 to $519.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $519.80 to $520.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.